The penalties will be as much as 2 percent of Medicare reimbursements, and could be worth millions of dollars to large nursing-home chains with locations spread across Indiana and the nation.
The health system said the 15-year-old elevated train service needs major maintenance, but did not say whether the system would ever return to service.
David Johnson, who has led the life science advocacy and investment group for 14 years, will take over full-time leadership of the Central Indiana Corporate Partnership in 2019.
Entrepreneur Michael Arnolt teamed with an inventor more than 20 years ago to launch an enterprise that has sold thousands of steel therapy instruments and trained thousands of clinicians.
The company is planning to add up to 1,330 jobs over the next eight years, focused mainly on its Regentec division in Indianapolis and its Profile Park in Bloomington, site of a former GE refrigerator factory.
Solinftec said Thursday it would invest $50.6 million to establish operations in the Hoosier state. The company makes technology that helps farmers collect and analyze data to increase crop returns.
At issue in the five-year legal dispute was whether Dr. Rick Sasso was properly compensated for various inventions, and whether Minnesota-based Medtronic paid him sufficient royalties as spelled out in their agreements.
It’s the foundation’s first capital campaign since 2010, when it raised $200 million. The money will be used for pediatric research, patient care, maternity and newborn health, and family support programs.
Dr. John Williams, dean since 2010, is stepping down next summer after turning 67, in accordance with university policy. He helped raise more than $70 million and expanded the school’s clinical space by about one-third.
The crisis has been years in the making, and the job of wrestling it to the ground has grown into a massive task. No one is yet predicting when the state will be able to declare victory.
The project will give the Indianapolis-based pharmaceutical company upgraded lab space as it pushes to launch more drugs for diabetes, cancer, pain and other ailments.
Indiana, one of the largest per-capita energy consumers in the nation, ranks 40th among states for energy efficiency, according to the American Council for an Energy-Efficient Economy.
The society, which has lost more than half its membership in the past two decades, is looking for a new home for many historical items, including a 1910 Waltham Gothic revival grandfather hall clock, a painting by Hoosier artist T.C. Steele and historic medical treatment books and documents.
The researchers are testing the effectiveness of a small, targeted molecule to prevent or reverse chemotherapy-induced peripheral neuropathy—a nerve problem that causes pain, numbness and tingling.
Executives and directors of the West Lafayette-based biotech hold nearly 9 percent of Endocyte stock, worth about $177 million, based on the deal price of $24 a share.
A few influential “serial entrepreneurs” in Indiana universities feel an itch to turn their discoveries into products and companies, over and over again.
The NCAA, which has been sued dozens of times for its role in handling concussions, will help fund an expanded $22.5 million study to examine the impacts of head injuries.
Two reports, sponsored by the Richard M. Fairbanks Foundation, say the state should not let up in fighting twin scourges that claim thousands of lives and cost billions of dollars in health care costs and lost productivity.
The Bloomington-based maker of medical devices will use the building at 1102 Indiana Ave. to do research on cell and gene therapy in collaboration with the Indiana University School of Medicine and other organizations.
The acquisitions are the first for IEA since it went public this spring, and signal that the company is pushing hard for more growth in the booming renewable energy sector.
